Therapeutic administration of KM+ lectin protects mice against Paracoccidioides brasiliensis infection via interleukin-12 production in a toll-like receptor 2-dependent mechanism

American Journal of Pathology

Volumn 173, Issue 2, 2008, Pages 423-432

  Coltri, Kely C ^a   Oliveira, Leandro L ^a   Pinzan, Camila F ^a   Vendruscolo, Patrícia E ^a   Martinez, Roberto ^a   Goldman, Maria Helena ^a   Panunto Castelo, Ademilson ^a   Roque Barreira, Maria Cristina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; JACALIN; KM+ LECTIN; MANNOSE BINDING LECTIN; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROL GROUP; CYTOKINE PRODUCTION; DRUG BINDING; GRANULOMA; LUNG HOMOGENATE; MALE; MOUSE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PRIORITY JOURNAL; SOUTH AMERICAN BLASTOMYCOSIS;

EID: 48749096868     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080126     Document Type: Article

References (66)

1. Brummer E, Castaneda E, Restrepo A: Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993, 6:89-117
2. McEwen JG, Bedoya V, Patino MM, Salazar ME, Restrepo A: Experimental murine paracoccidiodomycosis induced by the inhalation of conidia. J Med Vet Mycol 1987, 25:165-175
3. Almeida SR, Moraes JZ, Camargo ZP, Gesztesi JL, Mariano M, Lopes JD: Pattern of immune response to GP43 from Paracoccidioides brasiliensis in susceptible and resistant mice is influenced by antigen-presenting cells. Cell Immunol 1998, 190:68-76
4. Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon NL, Mota NG: Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop 1987, 20:129-132
5. Arango M, Oropeza F, Anderson O, Contreras C, Bianco N, Yarzabal L: Circulating immune complexes and in vitro cell reactivity in paracoccidioidomycosis. Mycopathologia 1982, 79:153-158
6. Scott P, Kaufmann SH: The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991, 12:346-348
7. Scott P, Pearce E, Cheever AW, Coffman RL, Sher A: Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 1989, 112:161-182
8. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549
9. Seder RA, Gazzinelli R, Sher A, Paul WE: Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming, Proc Natl Acad Sci USA 1993, 90:10188-10192
10. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A: Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995, 154:5071-5079
11. Calich VL, Kashino SS: Cytokines produced by susceptible and resistant mice in the course of Paracoccidioides brasiliensis infection. Braz J Med Biol Res 1998, 31:615-623
12. Gay NJ, Gangloff M: Structure and function of toll receptors and their ligands. Annu Rev Biochem 2007, 76:141-165
13. Pluddemann A, Mukhopadhyay S, Gordon S: The interaction of macrophage receptors with bacterial ligands. Expert Rev Mol Med 2006, 8:1-25
14. Yamada C, Sano H, Shimizu T, Mitsuzawa H, Nishitani C, Himi T, Kuroki Y: Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization, J Biol Chem 2006, 281:21771-21780
15. Frendeus B, Wachtler C, Hedlund M, Fischer H, Samuelsson P, Svensson M, Svanborg C: Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 2001, 40:37-51
16. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM: Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003, 197:1107-1117
17. Campbell D, Mann BJ, Chadee K: A subunit vaccine candidate region of the Entamoeba histolytica galactose-adherence lectin promotes interleukin-12 gene transcription and protein production in human macrophages. Eur J Immunol 2000, 30:423-430
18. Muraille E, Pajak B, Urbain J, Leo O: Carbohydrate-bearing cell surface receptors involved in innate immunity: interleukin-12 induction by mitogenic and nonmitogenic lectins. Cell Immunol 1999, 191:1-9
19. Hostanska K, Hajto T, Spagnoli GC, Fischer J, Lentzen H, Herrmann R: A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immun 1995, 14:295-304
20. Pryjma J, Ernst M, Fetting R, Woloszyn M, Zembala M, Flad HD: The role of monocytes in the induction and regulation of IFN-gamma production by lectin-activated human T lymphocytes. Eur Cytokine Netw 1991, 2:273-279
21. Panunto-Castelo A, Souza MA, Roque-Barreira MC, Silva JS: KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection. Glycobiology 2001, 11:1035-1042
22. Fava-Netto C, Vegas VS, Sciannameá IM, Guarnieri DB: Antígeno polissacarídeo do Paracoccidioides brasiliensis. Estudo do tempo de cultivo do Paracoccidioides brasiliensis, necessário ao preparo do antígeno, Rev Inst Med Trop São Paulo 1969, 11:177-181
23. Calich VL, Purchio A, Paula CR: A new fluorescent viability test for fungi cells. Mycopathologia 1979, 66:175-177
24. Santos-de-Oliveira R, Dias-Baruffi M, Thomaz SM, Beltramini LM, Roque-Barreira MC: A neutrophil migration-inducing lectin from Artocarpus integrifolia. J Immunol 1994, 153:1798-1807
25. da Silva LL, Molfetta-Machado JB, Panunto-Castelo A, Denecke J, Goldman GH, Roque-Barreira MC, Goldman MH: cDNA cloning and functional expression of KM+, the mannose-binding lectin from Artocarpus integrifolia seeds. Biochim Biophys Acta 2005, 1726:251-260
26. Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VL: The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J Med Vet Mycol 1992, 30:261-264
27. Yoshii C, Nagata N, Tao Y, Suematsu R, Nikaido Y, Kido M: Relationship between inflammatory cells in bronchoalveolar lavage fluid and pathologic changes in the lung interstitium. Respiration 1998, 65:386-92
28. Borges-Walmsley MI, Chen D, Shu X, Walmsley AR: The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol 2002, 10:80-87
29. Cano LE, Kashino SS, Arruda C, Andre D, Xidieh CF, Singer-Vermes LM, Vaz CA, Burger E, Calich VL: Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. Infect Immun 1998, 66:800-806
30. Diniz SN, Cisalpino PS, Freire AT, Silva-Teixeira DN, Contigli C, Rodrigues Junior V, Goes AM: In vitro granuloma formation. NO production and cytokines profile from human mononuclear cells induced by fractionated antigens of Paracoccidioides brasiliensis, Hum Immunol 2001, 62:799-808
31. Singer-Vermes LM, Caldeira CB, Burger E, Calich LG: Experimental murine paracoccidioidomycosis: relationship among the dissemination of the infection, humoral and cellular immune responses. Clin Exp Immunol 1993, 94:75-79
32. Benard G, Romano CC, Cacere CR, Juvenale M, Mendes-Giannini MJ, Duarte AJ: Imbalance of IL-2. IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis, Cytokine 2001, 13:248-252
33. Karhawi AS, Colombo AL, Salomao R: Production of IFN-gamma is impaired in patients with paracoccidioidomycosis during active disease and is restored after clinical remission. Med Mycol 2000, 38:225-229
34. Peraçoli MT, Kurokawa CS, Calvi SA, Mendes RP, Pereira PC, Marques SA, Soares AM: Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis. Microbes Infect 2003, 5:413-418
35. Romano CC, Mendes-Giannini MJ, Duarte AJ, Benard G: IL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific cellular immunosuppression of paracoccidioidomycosis patients. Cytokine 2002, 18:149-157
36. Romano CC, Mendes-Giannini MJ, Duarte AJ, Benard G: The role of interleukin-10 in the differential expression of interleukin-12p70 and its beta2 receptor on patients with active or treated paracoccidioidomycosis and healthy infected subjects. Clin Immunol 2005, 114:86-94
37. Arruda C, Franco MF, Kashino SS, Nascimento FR, Fazioli Rdos A, Vaz CA, Russo M, Calich VL: Interleukin-12 protects mice against disseminated infection caused by Paracoccidioides brasiliensis but enhances pulmonary inflammation. Clin Immunol 2002, 103:185-195
38. Arruda C, Valente-Ferreira RC, Pina A, Kashino SS, Fazioli RA, Vaz CA, Franco MF, Keller AC, Calich VL: Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern. Infect Immun 2004, 72:3932-3940
39. Parise-Fortes MR, da Silva MF, Sugizaki MF, Defaveri J, Montenegro MR, Soares AM, Peracoli MT: Experimental paracoccidioidomycosis of the Syrian hamster: fungicidal activity and production of inflammatory cytokines by macrophages. Med Mycol 2000, 38:51-60
40. Souto JT, Figueiredo F, Furlanetto A, Pfeffer K, Rossi MA, Silva JS: Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol 2000, 156:1811-1820
41. Nascimento FR, Calich VL, Rodriguez D, Russo M: Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J Immunol 2002, 168:4593-4600
42. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997, 100:2417-2423
43. Bocca AL, Hayashi EE, Pinheiro AG, Furlanetto AB, Campanelli AP, Cunha FQ, Figueiredo F: Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response. J Immunol 1998, 161:3056-3063
44. Suzuki Y: Immunopathogenesis of cerebral toxoplasmosis. J Infect Dis 2002, 186 Suppl 2:S234-240
45. Calvi SA, Peracoli MT, Mendes RP, Marcondes-Machado J, Fecchio D, Marques SA, Soares AM: Effect of cytokines on the in vitro fungicidal activity of monocytes from paracoccidioidomycosis patients. Microbes Infect 2003, 5:107-113
46. Carmo JP, Dias-Melicio LA, Calvi SA, Peracoli MT, Soares AM: TNF-alpha activates human monocytes for Paracoccidioides brasiliensis killing by an H2O2-dependent mechanism. Med Mycol 2006, 44:363-368
47. Shiloh MU, MacMicking JD, Nicholson S, Brause JE, Potter S, Marino M, Fang F, Dinauer M, Nathan C: Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 1999, 10:29-38
48. Allendoerfer R, Biovin GP, Deepe GS Jr: Modulation of immune responses in murine pulmonary histoplasmosis, J Infect Dis 1997, 175:905-914
49. Cain JA, Deepe GS Jr: Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum, Infect Immun 2000, 68:2069-2076
50. Deepe GS Jr, Romani L, Calich VL, Huffnagle G, Arruda C, Molinari-Madlum EE, Perfect JR: Knockout mice as experimental models of virulence. Med Mycol 2000, 38(Suppl 1):87-98
51. West AP, Koblansky AA, Ghosh S: Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006, 22:409-437
52. Netea MG, Van der Meer JW, Kullberg BJ: Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence. Clin Microbiol Infect 2006, 12:404-409
53. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088
54. Choe J, Kelker MS, Wilson IA: Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005, 309:581-585
55. da Silva Correia J, Ulevitch RJ: MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem 2002, 277:1845-1854
56. Ohnishi T, Muroi M, Tanamoto K: N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide. J Immunol 2001, 167:3354-3359
57. Ohnishi T, Muroi M, Tanamoto K: MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin Diagn Lab Immunol 2003, 10:405-410
58. Weber AN, Morse MA, Gay NJ: Four N-linked glycosylation sites in human toll-like receptor 2 cooperate to direct efficient biosynthesis and secretion. J Biol Chem 2004, 279:34589-34594
59. Kataoka H, Yasuda M, Iyori M, Kiura K, Narita M, Nakata T, Shibata K: Roles of N-linked glycans in the recognition of microbial lipopeptides and lipoproteins by TLR2. Cell Microbiol 2006, 8:1199-1209
60. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, Pulendran B: Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003, 171:4984-4989
61. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194:863-869
62. Trinchieri G, Sher A: Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007, 7:179-190
63. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A: Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005, 6:769-776
64. Delbridge LM, O'Riordan MX: Innate recognition of intracellular bacteria. Curr Opin Immunol 2007, 19:10-16
65. Odds FC, Brown AJ, Gow NA: Antifungal agents: mechanisms of action. Trends Microbiol 2003, 11:272-279
66. Romani L: Immunity to fungal infections. Nat Rev Immunol 2004, 4:1-23